Allogene Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Allogene Therapeutics, Inc. Website Screenshot

http://www.allogene.com

Allogene Therapeutics, Inc. Company Intro

A clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.

Industry

Healthcare

Allogene Therapeutics, Inc. Headquaters

210 East Grand Avenue
South San Francisco,94080
United States


Allogene Therapeutics, Inc. Share price

20 Oct 2020 01:04 GMT

$39.29

0.06 (0.15 %)


Allogene Therapeutics, Inc. Market cap

$5.062 B


WMC RANKING

2020

Allogene Therapeutics, Inc. # 322

Biotechnology



Latest Allogene Therapeutics, Inc. News

News 17 Oct 2020

Rotating into Defensives? CarParts.com Inc. (PRTS), Allogene Therapeutics Inc. (ALLO)

Allogene Therapeutics Inc. (ALLO) shares on Friday's trading session, dropped -0.86 percent to see the stock exchange hands at $39.23 per unit. Lets a quick ...

News 17 Oct 2020

Will current price volatility hamper Allogene Therapeutics, Inc. (ALLO) future potential?

Allogene Therapeutics, Inc. (NASDAQ:ALLO) has a beta value of 0 and has seen 527,187 shares traded in the last trading session. The company, currently ...

News 17 Oct 2020

Oct 16, 2020 - Allogene Therapeutics Inc (ALLO) CFO Eric Thomas Schmidt Sold $607,350 of Shares

The total sale was $607,350. Allogene Therapeutics Inc has a market cap of $5.46 billion; its shares were traded at around $39.23 . GuruFocus has detected 2 ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Allogene Therapeutics, Inc. 0 2.03 3.68 0 0 0 4.18
Alexion Pharmaceuticals, Inc. 100 11.32 100 20 0 0 96.20
Vertex Pharmaceuticals Incorporated 97.58 100 3.68 33 0 0 100
3SBio Inc. 96.05 0 0 0 0 0 0.06
Incyte Corporation 40.27 8.70 7.11 100 0 0 84.84

Allogene Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Allogene Therapeutics, Inc. $0 $170,479 $-154,073 $5.464B 322
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $27.206B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $56.803B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥20.207B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.821B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Allogene Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Allogene Therapeutics, Inc. Post vs Top 4 Industry Competitors